HSF1 and breast carcinoma: The mechanism of supportive action of HSF1 in ER-positive cells was already proposed, by which upon E2 treatment HSF1 is phosphorylated via ERα/MAPK signaling, gains transcriptional competence, and activates several genes essential for breast cancer cell growth and/or ERα action (Vydra et al., 2019).